ESCO (NYSE:ESE) Misses Q2 CY2026 Revenue Estimates

ESCO (NYSE:ESE) reported Q2 CY2026 revenue of $339 million, up 14.4% year on year, but below analysts’ estimates. Full-year revenue guidance was $1.32 billion at the midpoint, near consensus. Non-GAAP adjusted EPS was $2.20, 3.9% above consensus. The stock fell 1.1% to $324.21 after the report.

Original reporting
Published Aug 6, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 10:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ESCO (NYSE:ESE) Misses Q2 CY2026 Revenue Estimates — source image
Decision brief

The 30-second read

$ESENeutralMed
01

Why it matters

Traders can reassess near-term demand and margin durability using the revenue miss, EPS beat, and guidance positioning versus consensus.

02

Market read

Q2 shows revenue underperformance versus estimates but profitable EPS outperformance, with full-year revenue near consensus and EPS guidance ahead, creating a mixed setup for the stock.

03

What to watch

The article notes EBITDA fell slightly short and cites analyst expectations for revenue growth decelerating to 7.2%, which could matter more than the EPS beat for valuation.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session reaction following Q2 results

Background

ESCO is an engineered products manufacturer serving aerospace, defense, and utility markets, and the article frames its Q2 performance versus Wall Street expectations.

Company-level read

Ticker impact

$ESENeutralMedium confidence
Context

ESCO reported Q2 CY2026 revenue of $339M, up 14.4% YoY but below Wall Street estimates, while adjusted EPS was $2.20 and beat consensus.

Expected impact

Near-term volatility likely, with downside risk if investors focus on the revenue miss and demand deceleration.

Evidence & confidence

The article provides concrete Q2 results (revenue miss, EPS beat) plus full-year revenue and EPS guidance versus consensus, which typically drives immediate repricing and sets a near-term narrative for demand.

Market effects

Defense and aerospace component suppliers may see read-through on near-term demand expectations if revenue misses persist.

No specific regional spillover beyond US industrials sentiment.

Limited global relevance; impacts are primarily within US industrials/defense supply chain expectations.

Counterpoint

The revenue miss may be temporary given full-year revenue guidance is near consensus and operating margin stability suggests costs are controlled.

Key entities

  • ESCO

    NYSE-listed engineered products manufacturer reporting Q2 CY2026 results and full-year guidance.

  • Wall Street estimates

    Consensus benchmarks for Q2 revenue, adjusted EPS, and full-year guidance cited in the article.

Related articles

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.

$RCELHighAI 9/10

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical (NASDAQ:RCEL) shares rose about 21.7% in premarket after it reported record Q2 results. Revenue was $21.7M, up 18% YoY and about 8% above estimates. Adjusted loss per share narrowed to $0.25 vs $0.30 expected. Full-year 2026 revenue guidance raised to $86M-$89M and cash-flow breakeven targeted for Q4 2026. BTIG upgraded to Buy with a $7.00 target.

$NETHighAI 9/10

Cloudflare shares jump after forecast raise on higher AI-driven spending

Cloudflare shares rose about 16% premarket after the company raised its full-year outlook, citing higher enterprise spending on AI infrastructure. Cloudflare now forecasts revenue of $2.86B to $2.87B and adjusted EPS of $1.25 to $1.26. Reuters also notes strong cloud growth at Amazon and rising developer additions.